OBIO
Orchestra BioMed Holdings Inc.
NASDAQ: OBIO · HEALTHCARE · BIOTECHNOLOGY
$3.80
-2.56% today
Updated 2026-04-29
Market cap
$239.94M
P/E ratio
—
P/S ratio
7.17x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Orchestra BioMed Holdings Inc. (OBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-26.18M | $-19.43M | $-29.29M | $-46.13M | $-50.56M | $-48.96M |
| Capital expenditures | $539000.00 | $274000.00 | $591000.00 | $78000.00 | $289000.00 | $489000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $221000.00 | $302000.00 | $3.41M | $7.63M | $10.62M | $11.98M |
| Free cash flow | $-26.72M | $-19.70M | $-29.88M | $-46.20M | $-50.85M | $-49.45M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |